CROWELL GAYLE A Insider Trades

Insider Trading History

Track insider trading activity for CROWELL GAYLE A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $78.4k 70,000 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$79.8k 70,000 shares
$1.14
$1.12
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $1.57M 97,589 shares
Last Trade
Mar 26, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$105k 7,317 shares
$14.35
$16.11
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $2.42M 97,589 shares
Last Trade
Mar 26, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$183k 7,317 shares
$24.99
$24.81
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $2.17M 87,458 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$168k 6,600 shares
$25.45
$24.81
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $1.41M 87,458 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$100k 6,600 shares
$15.20
$16.11
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $1.95M 78,727 shares
Last Trade
Nov 03, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$151k 6,000 shares
$25.12
$24.81
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $1.27M 78,727 shares
Last Trade
Nov 03, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$107k 6,000 shares
$17.77
$16.11
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $33.6k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.12
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $1.72M 69,344 shares
Last Trade
May 08, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$150k 5,999 shares
$25.00
$24.81
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $1.12M 69,344 shares
Last Trade
May 08, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$105k 5,999 shares
$17.49
$16.11
Envestnet
Envestnet ENV
Director
Holding Value $0 0 shares
Last Trade
Nov 25, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$243k 3,852 shares
$63.15
$63.14
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $1.47M 59,366 shares
Last Trade
Aug 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$143k 5,790 shares
$24.75
$24.81
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $956k 59,366 shares
Last Trade
Aug 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$105k 5,790 shares
$18.06
$16.11
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $863k 53,576 shares
Last Trade
Jun 25, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.1k 701 shares
$20.05
$16.11
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $1.33M 53,576 shares
Last Trade
Jun 25, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.4k 701 shares
$24.79
$24.81
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $1.31M 52,874 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75.1k 3,030 shares
$24.79
$24.81
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $852k 52,874 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60k 3,030 shares
$19.80
$16.11
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $30k 26,764 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 26,764 shares
$13.06
$1.12
Envestnet
Envestnet ENV
Director
Holding Value $1.08M 17,075 shares
Last Trade
Feb 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 3,987 shares
$51.53
$63.14
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $769k 47,740 shares
Last Trade
Nov 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.9k 1,200 shares
$15.74
$16.11

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up